Strategies To De-escalate Aggressive Behavior in Psychiatric Patients

Gaynes BN, Brown C, Lux LJ, Brownley K, Van Dorn R, Edlund M, Coker-Schwimmer E, Zarzar T, Sheitman B, Palmieri Weber R, Viswanathan M, Lohr KN. Strategies To De-escalate Aggressive Behavior in Psychiatric Patients. Comparative Effectiveness Review No. 180. (Prepared by the RTI-UNC Evidence-based Practice Center under Contract No. 290-2015-00011-I) AHRQ Publication No. 16-EHC032EF. Rockville, MD: Agency for Healthcare Research and Quality. July 2016.

 

Links

• Full report
• Psychiatric Services article

Related Documents

• None

 

Abstract

Objective

To compare the effectiveness of strategies to prevent and de-escalate aggressive behaviors in psychiatric patients in acute care settings, including interventions aimed specifically at reducing use of seclusion and restraint.

Data Sources

We searched MEDLINE®, Embase®, the Cochrane Library, Academic Search Premier, PsycINFO, and CINAHL from January 1, 1991, through February 3, 2016. We manually searched reference lists of pertinent reviews, included trials, and background articles to identify relevant citations that our searches might have missed. Eligible studies included randomized controlled trials (RCTs), cluster randomized trials (CRTs), and observational and noncontrolled studies with sample sizes greater than 100. Eligible studies were limited to acute care settings and adult patients with psychiatric disorders or severe psychiatric symptomatology (excluding dementia); they had to report on aggression or seclusion and restraint outcomes.

Study Selection

Two investigators independently selected English-language studies using a priori criteria. Eligible studies included randomized, controlled trials (RCTs) of screening or preventive interventions for genital HSV infection, RCTs assessing the benefits or harms of preventive interventions aimed at reducing transmission or future symptomatic episodes of genital herpes, studies evaluating accuracy of serologic screening tests for HSV-2, systematic reviews (and studies published after eligible systematic reviews) evaluating the accuracy of serologic tests or harms of screening, multi-institution antiviral medication pregnancy exposure registries, and trials or observational studies assessing the harms of serologic screening.

Review Method

Two investigators independently selected, extracted data from, and rated risk of bias of studies. Risk of bias and strength of evidence (SOE) were assessed only for controlled studies. Twenty-nine primary studies (from 31 articles) met inclusion criteria. Of these, 11 were controlled trials that provided eligible data for SOE grades. Only 4 of these trials took place in the United States. We grouped studies as follows: (1) staff training interventions, (2) risk assessment interventions, (3) multimodal interventions, (4) environmental interventions (including group psychotherapeutic options), and (5) medication protocols versus other medication protocols or alternative strategies. We organized results by three key questions; these covered benefits, harms, and potential modifying characteristics of these strategies.

Results

Evidence was limited for benefits and, especially, for harms; information about modifying characteristics was completely absent. No key questions had data supporting SOE grades better than low, indicating limited confidence that the estimate of effect lies close to the true effect for these outcomes. The available evidence comprised primarily pre/post studies whose inherent high risk of bias precludes drawing inferences of causality. Of the 11 trials eligible for SOE assessment, all but 1 had medium (or high) risk of bias. Risk assessment had low SOE for decreasing subsequent aggression and reducing use of seclusion and restraint, but only when applied in a preventive manner (e.g., as unit-wide programs). SOE for all other interventions, whether aimed at preventing aggression or de-escalating aggressive behavior, was insufficient.

Conclusions

Given the ethical imperative for treating all patients with dignity, the clinical mandate of finding evidence-based solutions to these mental health challenges, and the legal liability associated with failure to assess and manage violence risk across the treatment continuum, the need for evidence to guide decisionmaking for de-escalating aggressive behavior is critical. The available evidence about relevant strategies is very limited. Only risk assessment decreased subsequent aggression or reduced use of seclusion and restraint (low SOE). Evidence for de-escalating aggressive behavior is even more limited. More research is needed to guide clinicians, administrators, and policymakers on how to best prevent and de-escalate aggressive behavior in acute care settings.